Xu Chen

Papers

1

Total Citations

20

H-Index

1

About

Xu Chen is an emerging surgical researcher whose work sits at the intersection of robotic surgery and urologic oncology. His most notable contribution to date is a landmark prospective, double-center, randomized controlled trial comparing the KangDuo Surgical System to the industry-standard da Vinci Si System for robot-assisted radical prostatectomy, published in 2024. This study is particularly significant as it represents one of the first rigorous clinical evaluations of a domestically developed Chinese robotic surgical platform in a head-to-head comparison with the globally dominant da Vinci system — a comparison with profound implications for surgical accessibility, healthcare economics, and technological sovereignty in minimally invasive surgery. Already accumulating 20 citations within a short period of publication, the work has quickly attracted attention from the surgical robotics community worldwide. Chen's research addresses a critical need for validated alternatives to Western-manufactured surgical systems, potentially expanding the global reach of robotic-assisted procedures. His contributions position him as a promising voice in the rapidly evolving field of next-generation robotic urology, where rigorous comparative evidence remains scarce but urgently needed.

Research Focus

Key Achievements

1
H-Index
1
Papers
20
Total Citations
20
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Radical Prostatectomy with the KangDuo Surgical System Versus the da Vinci Si System: A Prospective, Double-center, Randomized Controlled Trial
20 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 20

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago